Thank you, Richard. For the Q3 of 2024, CMTG reported a GAAP net loss of $0.40 per share and distributable loss of $0.17 per share. Distributable earnings per share prior to realized losses were $0.22 per share. CMTG's loan held for investment portfolio decreased to $6.3 billion at September 30 compared to $6.8 billion at June 30. The quarter-over-quarter decrease was the result of several moving parts. First, the third quarter was an active quarter with regard to loan repayments. We received a total of $374 million in loan repayments, including the full repayment of 4 loans totaling $354 million of UPB. The loan repayments during the quarter translated to reductions in relatively more challenging property types, including office and life science, while also reducing our total future funding commitment through the repayment of two construction loans. Included in the $354 million of full repayments, we were repaid on $123 million previously four rated New York office loan. CMTG's office exposure has historically been relatively small at only 14% of the portfolio at quarter end and our pre-COVID negative sentiment towards the sector has proven beneficial throughout this cycle. We were also repaid on a $109 million Boston Life Science loan, an asset class that has been under pressure. Rounding out this quarter's repayments, we received repayment on two construction loans, a $99 million loan on an industrial project in Nevada and a $23 million loan on a build to rent project in Georgia. Partially offsetting total repayments during the period was the impact of $186 million in fundings on new and existing loan commitments. As a result of the fundings and repayment of the construction loans, our future funding commitments decreased to $584 million at September 30 from $749 million at June 30. Of the $584 million our expected future net equity commitment is $185 million which we expect to fund over the course of about 2 years. At quarter end, we reclassified three loans to held for sale. The fact pattern surrounding each of the three loans held for sale are distinct and our decision to sell represents our view of the optimal outcome for CMTG given a variety of facts and circumstances. The first loan a $30 million subordinate and unencumbered loan secured by to be developed land in Miami was originated in July of 2021. Upon reaching its initial maturity date in July, 2023, the borrower exercised its right to extend the loan to its fully extended maturity date of July, 2024. In July, 2024, we agreed to a modification with the borrower to further extend the loan to September, 2024, as the borrower working towards a refinancing. When we reached the September, 2024 maturity date, the borrower requested additional time to execute the refinancing. In order to minimize the impact of the execution risk, we pivoted our strategy and were able to sell the loan at 99.5% of par. The sale closed subsequent to the quarter in early October, realizing an investment level gross IRR above 15%. The second loan, a $211 million senior and unencumbered California for sale condo loan was originated in October, 2019 and had been downgraded to risk grade for in the second quarter of this year. From 2022 through the summer of 2023, we received $83 million in loan repayments reducing our UPB from just under $300 million. As we mentioned, on our last earnings call, the borrower relied on offshore capital sources, which resulted in disruption in the borrower's business plan. After assessing our options, we determined that a loan sale was our most appropriate path and based on initial pricing feedback recorded a charge off for the accrued interest receivable and a $28 million principal charge off upon reclassifying the loan to help for sale. The third loan, $115 million senior loans secured by a multi-family building in Colorado was originated in August of 2022. This is a three-risk rated loan, which has been performing since origination with an initial maturity date set for next summer. During the quarter, we received an offer to sell this loan at a small discount to UPB that approximated our general CECL reserve. Given the environment, we made the decision to execute on the sale and repurpose the capital to deleverage existing financings, which will increase our net interest margin and reduce our average advance rates. We view this in similar selective loan sales as important steps in repositioning the portfolio and related financings, and enabling us to pivot towards offense over time. In light of all this activity, the portfolio's composition remained relatively in line with the prior quarter. Multifamily continues to be our biggest exposure at 42% of the portfolio at quarter end. As Richard mentioned, we remain optimistic on multifamily. However, the elevated rate environment has been challenging for multifamily borrowers and we continue to see this theme persist in our portfolio. As a result, during the third quarter, and consistent with what we have seen year-to-date, credit migration has been concentrated within our multifamily book. During a quarter, we moved two multifamily loans to a four-risk rating, representing a total UPB of $325 million. These loans with the same sponsor and are collateralized by assets located in Denver and Phoenix. The sponsor has experienced difficulties accessing the capital markets, and while we have a positive long-term outlook on housing in these markets, we believe it was prudent to proactively downgrade these loans. We also moved three multifamily loans to a five-risk rating. These three loans have the same sponsor and a combined UPB of $186 million and are collateralized by assets located in Las Vegas, Phoenix, and Dallas. These three loans were placed on nonaccrual status in the Q1, and the decision to further downgrade was made in anticipation of taking ownership of the assets over the next quarter or 2. As part of this process, we recorded specific reserves of $30 million collectively against these loans representing 16% of UPB. It's important to note that this reflects the current valuation of these assets and does not reflect what we view as long term value of these assets under our management. We believe that leveraging our sponsors' extensive multifamily experience will enable us to successfully execute a value-add plan to improve cash flow over time and, as a result, the asset's value. Turning to liquidity. At September 30, we reported $116 million in total liquidity, which includes cash and approved and undrawn credit capacity based on existing collateral. Unencumbered assets were comprised of loans totaling $459 million of UPB, including $213 million of loans classified is for sale in our mixed juice REO with a carrying value of $146 million. I'll now turn the call over to the operator.